Joslin Diabetes Center and Epocrates Launch Innovative Diabetes Resource for Clinicians
Clinicians across America now have access to the knowledge and opinions of a renowned diabetes expert, thanks to a collaboration between Joslin Diabetes Center and Epocrates Inc., a leading developer of handheld clinical applications.
Richard Jackson, M.D., Director of Medical Affairs, Healthcare Services, Joslin Diabetes Center, is the sole contributing editor for Epocrates’ new diabetes mobile resource center. This convenient handheld resource is designed to provide an intelligent, editorially independent summary of the most important clinical news and research in diabetes.
With diabetes rates on the rise among Americans, and the influx of medical news and developments, clinicians need a trusted source to help them sort through the clutter and keep current. The mobile resource center’s content, including scientific articles, research findings and breaking news, is selected and commented upon by Dr. Jackson to support clinicians’ care of patients with diabetes and its related conditions.
“This is a powerful way for healthcare professionals across all disciplines to quickly receive the latest diabetes research, news and information,” said Dr. Jackson, an Assistant Professor of Medicine at Harvard Medical School. “It’s a great forum for me to share compelling, real-time diabetes updates with other clinicians on the front lines of diabetes care.”
Dr. Jackson’s commentary, along with an integrated rating system, identifies the clinical significance of the information in order to help healthcare professionals stay current in a time-efficient manner. In a recent entry, Dr. Jackson addressed confusion regarding how aggressively pregnant women should be screened for diabetes. He presents recommendations from various governing bodies clearly and distills it in a way that clinicians can digest and apply to their practice.
“Through working with Dr. Jackson, as well as a leading organization such as Joslin, we can give our subscribers access to knowledge and resources they otherwise may not have immediately available to them,” said Kirk Loevner, chief executive officer and chairman for Epocrates.
About Richard Jackson, M.D.
Richard Jackson, M.D., Director of Medical Affairs, Healthcare Services, Joslin Diabetes Center is a senior investigator in Joslin’s Section on Immunology and Immunogenetics, where he established the Hood Center for Prevention of Childhood Diabetes and was part of the first multi-center clinical trials for prevention of type 1 diabetes.
He has authored more than 100 articles and reviews in peer-reviewed journals and has served on review boards for the National Institutes of Health, the American Diabetes Association, the Juvenile Diabetes Research Foundation, and the Canadian Diabetes Association.
Page last updated: February 11, 2016